Prosecution Insights
Last updated: July 17, 2026
Application No. 18/529,059

SYNTHESIS OF AMINOALKYL-SUBSTITUTED DISILOXANES

Non-Final OA §102§103
Filed
Dec 05, 2023
Priority
Dec 06, 2022 — provisional 63/386,231
Examiner
VALLE, ERNESTO
Art Unit
1623
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
GE Infrastructure Technology LLC
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
9m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
14 granted / 23 resolved
+0.9% vs TC avg
Strong +36% interview lift
Without
With
+35.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
48 currently pending
Career history
77
Total Applications
across all art units

Statute-Specific Performance

§103
60.7%
+20.7% vs TC avg
§102
11.0%
-29.0% vs TC avg
§112
9.8%
-30.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 23 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority This application claims priority to U.S. Provisional Application Serial No. 63/386,231, filed on December 6, 2022. Information Disclosure Statement The information disclosure statements (IDS) submitted on 12/05/2023, 02/09/2024, 05/01/2024, 05/23/2024, 07/16/2024, 08/05/2024, 09/19/2024, 01/09/2025, and 03/27/2025 were filed in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statements are being considered by the examiner. Status of the Application Applicant's election without traverse of Group I, claims 1-19 in the reply filed 04/13/2026 is acknowledged. Claims 1-22 are pending. Claims 20-22 have been withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claims 1-19 are currently under examination. Specification The disclosure is objected to because of the following informalities: IDS dated 09/19/2024 is missing name of patentee. Appropriate correction is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-13 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Li (Novel silicone aliphatic amine curing agent for epoxy resin: 1,3-Bis(2-aminoethylamino methyl, tetramethyldisiloxane. 1. Non-isothermal cure and thermal decomposition property 2012, pgs. 75-81). Li teaches the characterization and synthesis of 1,3-bis(2-aminoethylamino methyl) tetramethyl disiloxane (SFA), wherein ethylenediamine and chloromethyl ethoxy dimethyl silane are combined with a magnetic stirrer for a total of 4 hours in a first reaction prior to a second reaction wherein the raw product from the first reaction and distilled water are combined for a period of 2 hours to form the SFA product at 76% yield (2.2, pg. 76). Li’s compound of SFA anticipates the compound of formula I and formula IV (R18 and R19) and the 7th compound of instant claim 3 where R12-15 are methyl, R16 and R17 are CH2, R25-26, R29-32 and R36 are H, R33 and R34 are C and m is 0. PNG media_image1.png 78 390 media_image1.png Greyscale 1,3-bis(2-aminoethylaminomethyl) tetramethyl disiloxane (SFA)(Above) Applicants disiloxane compound of instant claim 3 (Below) PNG media_image2.png 84 515 media_image2.png Greyscale PNG media_image3.png 135 431 media_image3.png Greyscale PNG media_image4.png 167 461 media_image4.png Greyscale Regarding claim 4, Li’s use of ethylenediamine (bottom right) anticipates the compound of formula II of the instant claims where R1-2 and R5-8 are H, R9 and R10 are C and n is 0. PNG media_image5.png 176 424 media_image5.png Greyscale PNG media_image6.png 122 304 media_image6.png Greyscale Regarding claims 5 and 6, Li’s disclosure of chloromethylethoxydimethylsilane (Bottom Right) anticipates the compound of formula III (Bottom Left) of the instant claims where R24 is a C2 alkyl, R21-22 are methyl, R23 is CH3 and R20 is Cl. PNG media_image7.png 125 344 media_image7.png Greyscale PNG media_image8.png 133 180 media_image8.png Greyscale Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 1-19 is rejected under 35 U.S.C. 103 as being unpatentable over Li (Novel silicone aliphatic amine curing agent for epoxy resin: 1,3-Bis(2-aminoethylamino methyl, tetramethyldisiloxane. 1. Non-isothermal cure and thermal decomposition property 2012, pgs. 75-81) in view of Lee (Organic–inorganic hybrid materials from a new octa(2,3-epoxypropyl)silsesquioxane with diamines, Polymer, Volume 46, Issue 7,2005). The instant claims are directed to a method of preparing an aminoalkyl-substituted disiloxane by: I) forming a mixture of a di- or polyamine containing at least one primary amine group; and a silane; II) reacting the mixture in a first reaction by stirring for a period of 1 second to 12 hours Ill) adding a hydrolysis agent of water to the mixture over a period of 1 second to 12 hours; and IV) reacting the mixture in a second reaction to form the aminoalkyl-substituted disiloxane. Followed by purifying the aminoalkyl-substituted disiloxane and at least one step involves adjusting temperature by cooling the mixture. Li et al. teach the characterization and synthesis of 1,3-bis(2-aminoethylaminomethyl) tetramethyl disiloxane (SFA), wherein ethylenediamine and chloromethylethoxydimethylsilane are combined with a magnetic stirrer for a total of 4 hours in a first reaction prior to a second reaction of the raw product and distilled water are combined for a period of 2 hours wherein the SFA was produced at 76% yield with vacuum distillation (2.2, pg. 76). Li discloses “Lee and Chen [8] synthesized a POSS-contained epoxy resin, octa(2,3-epoxypropyl)silsesquioxane, from octa-allylsilsesquioxane with m-chloroperebenzoic acid, and cured them with methylenedianiline (DDM). The cured materials showed storage modulus of 1.8 GPa (30°C)” (introduction, pg. 75). PNG media_image1.png 78 390 media_image1.png Greyscale 1,3-bis(2-aminoethylaminomethyl) tetramethyl disiloxane (SFA)(Above) Applicants disiloxane compound of instant claim 3 (Below) PNG media_image2.png 84 515 media_image2.png Greyscale However, Li et al. fail to disclose a one pot synthesis or adding the hydrolysis agent dropwise or cooling the mixture in the second synthesis. Lee et al. teach a one pot synthesis of Octaallylsilsesquioxane (OA) wherein “[i]nto a 100 ml three-necked round bottom flask were added 10.29 g H2O (0.571 mmol), 0.8 g concentrated HNO3, and 2.93 g DMSO (0.038 mmol). 30.94 g ATMS (0.181 mol) and another 5.87 g (0.075 mol) DMSO were mixed and placed in an addition funnel and added dropwise into the flask in 3 h at 60 °C. Upon completion of addition, the mixture was allowed to react for 6 h and then cool to room temperature, kept in dark at ambient for crystallization around 10 days.” (2.2, pg. 2165) Lee also discloses “Although the yield of present synthesis is only 1.75%, the crystalline product is essentially pure and does not require sophisticated purification process” (2.2, pg. 2165) Therefore, it would have been prima facie obvious to a person of ordinary skill in the art, prior to the effective filing date of the instant application, to combine Li’s methods of synthesizing 1,3-bis(2-aminoethylaminomethyl) tetramethyl disiloxane (SFA) using the reagents of ethylenediamine and chloromethylethoxydimethylsilane using known techniques of stirring, purification by vacuum distillation and adjusting temperature, with Lee’s disclosure of dropwise addition of water through an addition funnel in a one pot process to synthesize an aminoalkyl-substituted disiloxane because a skilled artisan would have considered the methods Li referenced Lee’s methods of synthesizing octa(2,3-epoxypropyl)silsesquioxane and would have also seen the synthesis of Octaallylsilsesquioxane (OA), adapting the process for the required application such as scalability, cost, purity or synthesis time of SFA. See MPEP 2144.05(II) A person of ordinary skill in the art would have been motivated to synthesize the aminoalkyl-substituted disiloxane of 1,3-bis(2-aminoethylaminomethyl) tetramethyl disiloxane (SFA),by following Li’s disclosure of forming a mixture of a di- or polyamine containing at least one primary amine group; and a silane using the reagents of ethylenediamine and chloromethyl ethoxydimethylsilane and reacting the mixture in a first reaction by stirring for a period of 3 hours followed by 1 hour. Followed by adding a hydrolysis agent of water to the mixture over a period of 3 hours as disclosed by Lee and reacting the mixture in a second reaction to form the aminoalkyl-substituted disiloxane followed by purifying the aminoalkyl-substituted disiloxane by either vacuum distillation of crystallization and optimizing the temperature of the reaction by cooling the mixture. A skilled artisan, following the teachings of Li and Lee would have had a reasonable expectation of success in synthesizing the compound of an aminoalkyl-substituted disiloxane of SFA. Conclusion All claims are rejected, no claims are allowed. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERNESTO VALLE JR whose telephone number is (703)756-5356. The examiner can normally be reached 0730-1700 M-F EST, 1st Friday off. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Adam C Milligan can be reached at 571-270-7674. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /E.V./Examiner, Art Unit 1623 /SAMANTHA L SHTERENGARTS/Primary Examiner, Art Unit 1623
Read full office action

Prosecution Timeline

Dec 05, 2023
Application Filed
May 05, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673914
CONTINUOUS PROCESS FOR THE SYNTHESIS OF DIMETHYL CARBONATE OVER A CERIUM-BASED CATALYST FORMULATION
2y 11m to grant Granted Jul 07, 2026
Patent 12662460
COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE
3y 12m to grant Granted Jun 23, 2026
Patent 12589092
POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR
3y 9m to grant Granted Mar 31, 2026
Patent 12582628
METHODS FOR TREATING BREAST CANCER
3y 11m to grant Granted Mar 24, 2026
Patent 12564569
CARBOPLATIN COMPLEX AND PHARMACEUTICAL PREPARATION THEREOF
4y 0m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
97%
With Interview (+35.7%)
3y 4m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 23 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month